CD8A and neoplasm: While cDC1s are rare in human and murine tumors, they efficiently cross-present exogenous antigens to CD8+ T cells, are capable of initiating de novo cytotoxic CD8+ T cell responses after migrating to the tumor-draining lymph node, and play an integral role in re-priming CD8+ T cells directly in the TME [rev.